OpenAI acquiert la startup biotech IA Orchestra Bio
OpenAI ajoute les agents IA d’Orchestra Bio pour renforcer sa plateforme de sciences de la vie Rosalind, élargissant les services biotech.
Regarder sur YouTube · Regarder le court
OpenAI announced on October 20, 2026 that it has acquired Orchestra Bio, a four‑year‑old AI biotech software startup.
Orchestra Bio, backed by Andreessen Horowitz, Atria and 8VC with roughly $20 million raised by 2025, builds AI agents that manage drug‑discovery operations such as finance tracking and clinical‑trial scheduling.
The acquisition will integrate Orchestra’s team and technology into OpenAI’s Rosalind model and the Rosalind Workbench tool, which help researchers plan experiments and analyze results.
OpenAI cites existing Rosalind customers including Moderna and Novo Nordisk, indicating a growing market for AI‑driven life‑science tools.
Terms of the deal were not disclosed, and the move reflects a broader trend of large AI labs expanding into industry‑specific software.
Ce que cela signifie pour vous
For AI users, the deal signals more specialized tools that combine large models with workflow automation in biotech. Those seeking free or locally hosted models may see increased competition for resources as commercial AI labs deepen domain‑specific offerings.
Sources
- OpenAI acquires startup Orchestra Bio to beef up its biotech business, TechCrunch, 20 Oct 2026
- OpenAI acquires Orchestra Bio, OpenAI (official), 20 Oct 2026
Rédigé automatiquement à partir des sources ci‑dessus, puis vérifié par notre code : chaque nombre et chaque nom doivent y figurer, et aucune phrase ne doit copier une source. Une erreur ? Signalez‑la.
Quelle IA pouvez‑vous utiliser gratuitement aujourd’hui ?
Tous les modèles IA gratuits, classés par votes humains anonymes, avec la mémoire et la vitesse dont ils ont besoin sur votre propre GPU.